Abstract

Fabry disease is a rare X-linked lysosomal storage disorder resulting from a deficiency in the α-galactosidase A enzyme. Deficiency in the activity of this enzyme causes an accumulation of neutral glycosphingolipids, predominantly globotriaosylceramide (GL-3), in most nonneural tissues and in body fluids (1). Recent clinical studies indicate that tissue and plasma GL-3 concentrations in Fabry patients can be significantly reduced by enzyme replacement therapy (2)(3)(4)(5). GL-3 (see Fig. 1 in the Data Supplement that accompanies the online version of this Technical Brief at http://www.clinchem.org/content/vol51/issue1/) exists as a mixture of structural isoforms containing acyl chains ranging from 16 to 24 carbons in length with various degrees of saturation and hydroxylation. These variations make the extraction and quantification of GL-3 challenging (6)(7). Moreover, no well-characterized reference standards of known purity are available. GL-3 in tissues and plasma has been measured by thin-layer chromatography (8)(9), liquid chromatography (LC) (10)(11)(12)(13)(14)(15), and gas chromatography(16), but the methods are labor-intensive and slow. An enzyme-linked immunosorbent assay (17) requires recombinant verotoxin B and polyclonal rabbit anti-verotoxin B. To date, the most rapid quantitative assays for total GL-3 have used flow-injection tandem mass spectrometry (MS/MS) (18)(19). We now report the development and use of a rapid LC/MS/MS method for the quantitative determination of total plasma GL-3. Porcine GL-3 and porcine globotriaosylsphingosine A ( lyso -GL-3), from Matreya, were ≥98% pure by thin-layer chromatographic analysis. C16:0-GL-3 and C17:0-GL-3 were enzymatically synthesized from lyso -GL-3 at Genzyme Pharmaceuticals (18). C16:0-enriched GL-3 was prepared by gravimetrically combining C16:0-GL-3 and porcine GL-3 in a 9:25 g/g mass ratio. Methanol, water, and chloroform were HPLC grade. Normal heparin-plasma samples from 104 men and 101 women were obtained from Interstate Blood …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call